Zocor News and Research

RSS
Zocor (Simvastatin) is used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in your blood. Simvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body.
VUMC doctors to begin statin drug screening for rare genetic variation

VUMC doctors to begin statin drug screening for rare genetic variation

Merck third quarter global sales increase 8% to $12.0 billion

Merck third quarter global sales increase 8% to $12.0 billion

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Merck’s diabetes combo pill gets FDA nod

Merck’s diabetes combo pill gets FDA nod

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Foods that can reduce cholesterol

Foods that can reduce cholesterol

Zocor, Crestor drugs may cause serious muscle and kidney problems

Zocor, Crestor drugs may cause serious muscle and kidney problems

High dose statins raise risk of diabetes: Study

High dose statins raise risk of diabetes: Study

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

Merck receives FDA approval for redesigned drug container labels

Merck receives FDA approval for redesigned drug container labels

Larger trial study needed to decide fate of niacin

Larger trial study needed to decide fate of niacin

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin

U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin

Efficacy of Abbott cholesterol drug in question

Efficacy of Abbott cholesterol drug in question

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Synergy expands GC-C agonist technology to lower cholesterol

Synergy expands GC-C agonist technology to lower cholesterol

Merck first quarter sales increase 1% to $11.6 billion for 2011

Merck first quarter sales increase 1% to $11.6 billion for 2011

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides